U.S. Pharmacopeia at PepTalk 2027

Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website

U.S. Pharmacopeia brings 2 presentations to PepTalk 2027 in Carlsbad. Its sessions center on quality and regulatory expectations for peptide drugs. Topics include control strategies for peptide active ingredients from synthesis to approval, and how evidence generation builds regulatory certainty.

Organization	PepTalk 2027 Attendance
U.S. Pharmacopeia Rockville, MD
usp.org Gov/NGO Non-profit that sets public quality standards and supplies reference materials for medicines, including peptides and biologics.	Talk Wed Jan 20 3:00pm–3:30pm Building Robust Control Strategies for Peptide APIs: From Synthesis to Regulatory Approval Peptide Therapeutics: Emerging Modalities & Development Panel Wed Jan 20 5:40pm–6:10pm Stick to the Science—How Evidence Generation Can Build upon Technology Enthusiasm to Advance Both Regulatory Certainty and Market Momentum Peptide Therapeutics: Emerging Modalities & Development · with U.S. Food and Drug Administration, Novartis, ELIQUENT Life Sciences

Organization

PepTalk 2027 Attendance

U.S. Pharmacopeia

Rockville, MD

usp.org

Gov/NGO

Non-profit that sets public quality standards and supplies reference materials for medicines, including peptides and biologics.

Talk

Wed Jan 20
3:00pm–3:30pm

Building Robust Control Strategies for Peptide APIs: From Synthesis to Regulatory Approval

Peptide Therapeutics: Emerging Modalities & Development

Panel